RESUMO
INTRODUCTION: End-stage renal disease (ESRD) related to HIV is becoming a leading cause of renal replacement therapy requirement is some areas of the world. Our study aims to describe the incidence and renal outcomes of HIV-associated nephropathy (HIVAN), and immune-mediated kidney disease related to HIV (HIVICK) in Colombia. METHODOLOGY: A retrospective cohort study was performed, including all HIVAN or HIVICK incident cases assessed by the infectious diseases division in a high complexity institution in Colombia, between 2004 and 2018. A longitudinal data model under the Generalized Estimating Equations (GEE) method was used to determine changes on the glomerular filtration rate (GFR) over time. RESULTS: Within a cohort composed by 1509 HIV-infected patients, we identified 22 with HIV-associated glomerular disease. Cumulative incidence was 1.45%. At diagnosis, GFR was above 30 mL/min in 90.8% of patients, and 77.2% displayed sub-nephrotic proteinuria. Factors associated with GFR at diagnosis were: level of CD4 (Coefficient 0.113, CI 95 %: 0.046, 0.179, p < 0.01), and the inverse of the CD4/CD8 ratio. The GEE model did not demonstrate significant changes in the GFR over a 3-year period. Findings were similar when comparing GFR at diagnosis with GFR at 12 (-3.9 mL/min/1.73m2, CI 95% -7.3, 0.4, p = 0.98), 24 (-2.47 mL/min/1.73m2, CI 95% -7.0, 2.1, p=0.85), and 36 months (0.39 mL/min/1.73m2, CI 95% -4.4, 5.2, p = 0.43) of follow-up. CONCLUSIONS: Patients with glomerular disease associated with HIV have stable GFR over a 3-year period, and low rates of progression towards dialysis requirement. Differences with previous reports could be related with early diagnosis and treatment with highly active antiretroviral therapy.
Assuntos
Nefropatia Associada a AIDS/complicações , Nefropatia Associada a AIDS/epidemiologia , Terapia Antirretroviral de Alta Atividade , Infecções por HIV/complicações , Adulto , Contagem de Linfócito CD4/estatística & dados numéricos , Relação CD4-CD8/estatística & dados numéricos , Colômbia/epidemiologia , Progressão da Doença , Feminino , Seguimentos , Taxa de Filtração Glomerular , Infecções por HIV/tratamento farmacológico , HIV-1/efeitos dos fármacos , Humanos , Falência Renal Crônica/complicações , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Estudos RetrospectivosRESUMO
Resumen Objetivo: actualmente, en Colombia están en uso diferentes escalas para estimar el riesgo de morbimortalidad en pacientes con pancreatitis, lo que genera incertidumbre a la hora de clasificar y manejar a estos pacientes. El objetivo de este estudio es analizar la concordancia entre las más usadas en una población atendida a 2670 metros sobre el nivel del mar (msnm). Materiales y métodos: se evaluaron 200 pacientes, entre 18 y 65 años, con diagnóstico de pancreatitis aguda y manejados en el Hospital Universitario San Ignacio de Bogotá (Colombia). Se estimaron tres escalas de riesgo y se clasificaron como pancreatitis con predicción de gravedad si los puntajes de APACHE II eran ≥8, Marshall modificada ≥2, o si tenían 3 o más criterios de Ranson positivos. Se determinó la concordancia entre los resultados usando el estadístico kappa. Resultados: según Marshall, el 45,5 % de los pacientes correspondieron a pancreatitis con predicción de gravedad, mientras que de acuerdo con APACHE II y Ranson se encontró este diagnóstico en un 39,5 % y un 38,5 %, respectivamente. El coeficiente kappa mostró una concordancia débil entre APACHE II y Ranson (kappa: 0,201; intervalo de confianza [IC], 95 %: 0,05-0,34), así como una concordancia pobre entre Ranson y Marshall (kappa: 0,18; IC, 95 %: 0,04-0,32). La concordancia entre APACHE y Marshall fue moderada (kappa: 0,42; IC, 95 %: 0,28-0,56). Conclusiones: existe un pobre acuerdo entre las diferentes escalas de clasificación de riesgo de pancreatitis usadas en Colombia, por lo que no pueden interpretarse como clínicamente equivalentes. Los datos de este estudio demuestran la necesidad de validar las distintas escalas en Colombia y en Latinoamérica. Además, sugieren que la escala de Marshall sobreestima el riesgo en ciudades por encima de los 2000 msnm.
Abstract Introduction: Different scales to estimate the risk of morbidity and mortality in patients with pancreatitis are currently in use in Colombia, which leads to uncertainty when classifying and treating these patients. Objective: This study seeks to analyze agreement between the most used scales to estimate the risk of patient morbidity and mortality in a population treated at 2,670 meters above sea level (m.a.s.l.). Materials and methods: Two hundred patients between 18 and 65 years old, diagnosed with acute pancreatitis, were evaluated and treated at the Hospital Universitario San Ignacio, Bogotá (Colombia). Three risk scales were used for the estimations. Scores ≥ 8 in the APACHE II system, ≥ 2 in the Modified Marshall Score, or 3 or more positive Ranson criteria were classified as pancreatitis with severity prognostic marker. Agreement between the results was determined using the Kappa coefficient. Results: According to the Marshall score, 45.5% of the cases were pancreatitis with predicted severity, while APACHE II and Ranson yielded scores of 39.5% and 38.5%, respectively. The Kappa coefficient showed weak agreement between APACHE II and Ranson (Kappa=0.201; 95%CI 0.05-0.34), poor agreement between Ranson and Marshall (Kappa=0.18; 95%CI 0.04-0.32), and moderate agreement between APACHE II and Marshall (Kappa=0.42; 95%CI 0.28-0.56). Conclusions: There is poor agreement between the pancreatitis severity scoring systems used in Colombia, so they cannot be interpreted as clinically equivalent. The data from this study demonstrate the need to validate the scales in Colombia and Latin America. They also suggest that the Marshall scale overestimates the risk in cities above 2,000 m.a.s.l.